SCHEMBL26192910

SCHEMBL26192910

Cn1ccc(-c2cc(-c3ccc(F)cc3)ccc2[N+](=O)[O-])n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN4A P35499 1/20 0.46
▸ ATM Q13315 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ HTR7 P34969 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ FRK P42685 1/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ CSNK1A1 P48729 1/20 0.37
▸ EIF4E P06730 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ KEAP1 Q14145 1/20 0.36
▸ MAPK13 O15264 1/20 0.35
▸ CSNK1D P48730 1/20 0.35
▸ CSNK1E P49674 1/20 0.35
▸ MAPK12 P53778 1/20 0.35
▸ MAPK11 Q15759 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26192925 0.88 HPRT1 (0.43) ALDH1A1LMNAHTR7EIF4EKEAP1
SCHEMBL25379027 0.86 GAA (0.44) TDP1ALDH1A1EIF4ENTRK1KMT2A
SCHEMBL30510143 0.86 GAA (0.44) TDP1ALDH1A1EIF4ENTRK1KMT2A
SCHEMBL25296548 0.85 SCN4A (0.47) SCN4AATMTDP1ALDH1A1LMNA
SCHEMBL30362932 0.81 ATM (0.44) SCN4AATMTDP1ALDH1A1LMNA
SCHEMBL26193412 0.78 SCN4A (0.48) SCN4AATMTDP1ALDH1A1LMNA
SCHEMBL26192840 0.78 S100A4 (0.41) TDP1ALDH1A1LMNAHTR7KMT2A
SCHEMBL25377342 0.76 SCN4A (0.51) SCN4AMAP4K4EGFRFRKMAPK9
SCHEMBL26192909 0.76 SCN4A (0.51) SCN4ALMNAMAP4K4EGFRFRK
SCHEMBL25380258 0.75 GRIN1 (0.43) TDP1ALDH1A1LMNAGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 — — US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 SCN4A 4415/4885ATM 400/4885TDP1 1073/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 SCN4A 4415/4885ATM 400/4885TDP1 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback